Modulation of growth and differentiation of human colon carcinoma cells by histone deacetylase inhibitory trichostatins

International Journal of Oncology

Volumn 8, Issue 3, 1996, Pages 431-437

  Li, Xiaoli ^a   Yoshida, Minoru ^b   Beppu, Terohiku ^b   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Butyrate; Colon cancer; Differentiation; Histone deacetylase inhibition; Trichostatin

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE; TRICHOSTATIN A; TRICHOSTATIN C; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; COLON CARCINOMA; CONTROLLED STUDY; ENANTIOMER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029974613     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.3.431     Document Type: Article

References (43)

1. Kruh J: Effects of sodium butyrate, a new pharmacological agent on cells in culture. Mol Cell Biol 42: 65-82, 1982.
2. Kruh J, Defer N and Tichonicky L: Action moleculaire et cellulaire du butyrate. C R Soc Biol 186: 12-25, 1991.
3. Tsao D, Shi Z-R, Wong A and Kim YS: Effect of sodium butyrate on carcinoembryonic antigen production by human colonic adenocarcinoma cells in culture. Cancer Res 43: 1217-1222, 1983.
4. Gum JR, Kam WK, Byrd JC, Hicks JW, Sleisenger MH and Kim YS: Effects of sodium butyrate on human colonic adenocarcinoma cells: Induction of placental-like alkaline phosphatase. J Biol Chem 262: 1092-1097, 1987.
5. Barnard JA and Warwick G: Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 4: 495-501, 1993.
6. Ohannesian DW, Lotan D and Lotan R: Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, Lamp-1, and Lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Cancer Res 54: 5992-6000, 1994.
7. Otaka M, Singhal A and Hakomori S: Antibody-mediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vitro and in vivo: a preliminary note. Biochem Biophys Res Commun 158: 202-208, 1989.
8. Miller AA, Kurschel E, Osieka R and Schmidt CG: Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 23: 1283-1287, 1987.
9. Pouillart P, Ronco G, Cerutti I, Trouvin JH, Pieri F and Villa P: Pharmacokinetic studies of n-butyric acid mono- and polyesters derived from monosaccharides. J Pharm Sci 81: 241-244, 1992.
10. McNeil N, Cummings JH and James WPT: Short chain fatty acid absorption by the human large intestine. Gut 19: 819-822, 1978.
11. Raphaeli A, Rabizadeh E, Aviram A, Shaklai M, Ruse M and Nudelman A: Derivatives of butyric acid as potential anti-neoplastic agents. Int J Cancer 49: 66-72, 1991.
12. Nudelman A, Ruse M, Aviram A, Rabizadeh E, Shaklai M, Zimrah Y and Rephaeli A: Novel anticancer prodrugs of butyric acid. J Med Chem 35: 687-694, 1992.
13. Candido EPM, Reeves R and Davie JR: Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14: 105-113, 1978.
14. Davie JR and Candido EPM: Acetylated histone H4 is preferentially associated with template-active chromatin. Proc Natl Acad Sci USA 75: 3574-3577, 1978.
15. Tsuji N, Kobayashi M, Nagashima K, Wakisaka Y and Koizumi K: A new antifungal antibiotic, trichostatin A. J Antibiot 29: 1-6, 1976.
16. Yoshida M, Kijima M, Akita M and Beppu T: Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265: 17174-17179, 1990.
17. Yoshida M and Beppu T: Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res 177: 122-131, 1988.
18. Yoshida M, Nomura S and Beppu T: Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res 47: 3688-3691, 1987.
19. Yoshida M, Hoshikawa Y, Koseki K, Mori K and Beppu T: Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells. J Antibiot 43: 1101-1106, 1990.
20. Sugita K, Koizumi K and Yoshida H: Morphological reversion of sis-transformcd NIH3T3 cells by trichostatin A. Cancer Res 52: 168-172, 1992.
21. Hoshikawa Y, Kwon HJ, Yoshida M, Horinouchi S and Beppu T: Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res 214: 189-197, 1994.
22. Tsuji N and Kobayashi M: Trichostatin C, a glucopyranosyl hydroxamate. J Antibiot 31: 939-944, 1978.
23. Yoshida M, Iwamoto Y, Uozumi T and Beppu T: Trichostatin C, a new inducer of differentiation of Friend leukemic cells. Agric Biol Chem 49: 563-565, 1985.
24. Morikawa K, Walker SM, Jessup JM and Fidler IJ: In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinoma implanted into nude mice. Cancer Res 48: 1943-1948, 1988.
25. Lotan R, Kramer RH, Neumann G, Lotan D and Nicolson GL: Retinoic acid-induced modifications in the growth and cell surface components of a human carcinoma (HeLa) cell line. Exp Cell Res 130: 401-414, 1980.
26. Ho M-K and Springer TA: Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol 128: 1221-1228, 1982.
27. Fukuyama R, Minoshima S, Ochiai A, Tahara E and Shimizu N: Flow cytometric analysis of the expression of 9A3 antigen, E-cadherin, and EGF receptor in TMK-1 stomach cancer cells. Int J Cancer 48: 81-84, 1991.
28. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K: Current Protocol in Molecular Biology, Unit 12.1.1-12.1.2. Wiley Interscience, New York, 1990.
29. Meistrich ML, Trostle-Weige PK, Lin R, Bhatnagar YM and Allis CD: Highly acetylated H4 is associated with histone displacement in rat spermatides. Mol Rep Develop 31: 170-181, 1992.
30. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K and Stanners CP: Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327-334, 1989.
31. Davie JR and Hendzel MJ: Multiple functions of dynamic histone acetylation. J Cell Biochem 55: 98-105, 1994.
32. Lopez-Rodas G, Brosch G, Georgieva EI, Sendra R, Franco L and Loidl P: Histone deacetylase. A key enzyme for the binding of regulatory proteins to chromatin. FEBS Lett 317: 175-180, 1993.
33. Lee DY, Hayes JJ, Pruss D and Wolffe AP: A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72: 73-84, 1993.
34. Grunstein M: Histone function in transcription. Annu Rev Cell Biol 6: 643-678, 1990.
35. Durrin LK, Mann RK, Kayne PS and Grunstein M: Yeast histone H4 N-terminal sequence is required for promoter activation in vivo. Cell 65: 1023-1031, 1991.
36. Bohan C A Robinson RA, Luciw PA and Srinivasan A: Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat. Virology 172: 573-583, 1989.
37. Yin HL: Gelsolin: Calcium- and polyphosphoinositide-regulated actin-modulating protein. BioEssays 7: 176-179, 1987.
38. Dieffenbach CW, Sen Gupta DN, Krause D, Sawzak D and Silverman RH: Cloning of murine gelsolin and its regulation during differentiation of embryonal carcinoma cells. J Biol Chem 264: 13281-13288, 1989.
39. Vandekerckhove J, Bauw G, Vancompernolle K, Honore B and Celis J: Comparative two-dimensional gel analysis and microsequencing identifies gelsolin as one of the most prominent down regulated markers of transformed human fibroblast and epithelial cells. J Cell Biol 111: 95-102, 1990.
40. Mullauer L, Fujita H, Ishizaki A and Kuzumaki N: Tumor-suppressive function of mutated gelsolin in ray-transformed cells. Oncogene 8: 2531-2536, 1993.
41. Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T and Kuzumaki N: Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res 55: 3228-3232, 1995.
42. Porter RM, Holme TC, Newman EL, Hopewood D, Wilkinson JM and Cuschieri A: Monoclonal antibodies to cytoskeletal proteins: an immunohistochemical investigation of human colon cancer. J Pathol 170: 435-440, 1993.
43. Janmey PA and Stossel TP: modulation of gelsolin function by phosphatidylinositol 4,5-bisphosphate. Nature 325: 362-364, 1987.